Marius Lund-Iversen

8PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 26, 2024
Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal Cancer.

Vegar Johansen Dagenborg, Kristoffer Watten Brudvik, Christin Lund-Andersen

|Jan 19, 2024
Evaluation of NTRK expression and fusions in a large cohort of early-stage lung cancer.

Anne Pernille Harlem Dyrbekk, Abdirashid Ali Warsame, Pål Suhrke

|Apr 27, 2022
Factors affecting outcome in resected EGFR-mutated lung cancer.

Inger Johanne Zwicky Eide, Yngvar Nilssen, Marius Lund-Iversen

|Dec 28, 2020
Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer - predictors of response and impact of previous radiotherapy.

Åsa Kristina Öjlert, Daniel Nebdal, Marius Lund-Iversen

|Mar 27, 2020
Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study.

Anne Hansen Ree, Vigdis Nygaard, Kjetil Boye

|Feb 27, 2020
Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases.

Vegar Johansen Dagenborg, Serena Elizabeth Marshall, Sheraz Yaqub

Pageof 2

Frequent Collaborators

3 joint publications

Kjersti Flatmark

2 joint publications

Anne Hansen Ree

2 joint publications

Kjetil Boye

2 joint publications

Odd Terje Brustugun